Vaxxa delivered 40% revenue growth and its first positive net result, driven by a strategic shift to an intermediary auction model and strong auction volume growth. The company enters 2025 with a robust cash position and plans for international expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.